0 Bedömningar

ID

24355

Beskrivning

Study part: Study Conclusion Week 52.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.

Nyckelord

  1. 2017-07-30 2017-07-30 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

30 juli 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Study Conclusion Week 52 Ropinirole NCT00632736

    Study Conclusion Week 52

    STUDY CONCLUSION
    Beskrivning

    STUDY CONCLUSION

    Alias
    UMLS CUI-1
    C1707478 (Conclusion)
    UMLS CUI-2
    C0008972 (Clinical Research)
    The study conclusion page completed?
    Beskrivning

    Study conclusion

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1707478 (Conclusion)
    UMLS CUI [1,2]
    C0008972 (Clinical Research)

    Similar models

    Study Conclusion Week 52

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    STUDY CONCLUSION
    C1707478 (UMLS CUI-1)
    C0008972 (UMLS CUI-2)
    Study conclusion
    Item
    The study conclusion page completed?
    boolean
    C1707478 (UMLS CUI [1,1])
    C0008972 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial